Unleashing immunity against oral cancer with immune checkpoint inhibitors

Unleashing immunity against oral cancer with immune checkpoint inhibitors

Saved in:

Bibliographic Details
Main Author:	Ajay Guru
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	Oral Oncology Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906024003364
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Application of Immune Checkpoint Inhibitors in Cancer
by: Zhijun Chen, et al.
Published: (2025-08-01)

Immune-checkpoint inhibitor resistance in patients with cancer
by: Luis Cabezón-Gutiérrez, et al.
Published: (2025-05-01)

Negative Immune Checkpoint Inhibitors
by: Magda Drewniak-Świtalska, et al.
Published: (2025-05-01)

Research progress of immune checkpoint inhibitors in ovarian cancer
by: Lingli Zhao, et al.
Published: (2024-12-01)

Hepatotoxicity induced by immune checkpoint inhibitors
by: Flaviu Muresan, et al.
Published: (2024-10-01)

Pouchitis After Immune Checkpoint Inhibitors
by: Gabriel Sperling, et al.
Published: (2023-08-01)

Chronic immune checkpoint inhibitor pneumonitis
by: Julie R Brahmer, et al.
Published: (2020-05-01)

Adverse reactions of immune checkpoint inhibitors
by: E. R. Zagidullina, et al.
Published: (2025-06-01)

Immune Checkpoint Inhibitors in the Treatment of Lymphomas
by: KV Lepik
Published: (2018-10-01)

Immune Checkpoint Inhibitor-associated Pneumonitis: A Narrative Review
by: Chang Li, et al.
Published: (2025-02-01)

Cancer Immunotherapy: Targeting TREX1 Has the Potential to Unleash the Host Immunity against Cancer Cells
by: Karim Hawillo, et al.
Published: (2024-10-01)

Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer
by: Etienne Rouleau, et al.
Published: (2024-07-01)

Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacy
by: Olivia Le Saux, et al.
Published: (2025-08-01)

Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression
by: Tao Wang, et al.
Published: (2022-03-01)

Current trends in sensitizing immune checkpoint inhibitors for cancer treatment
by: Jing Wei, et al.
Published: (2024-12-01)

Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer
by: Jie Yao, et al.
Published: (2024-12-01)

Immune checkpoint inhibitor-related myocarditis in patients with lung cancer
by: Wenli Cao, et al.
Published: (2025-04-01)

Resistance to immune checkpoint inhibitors in the treatment of metastatic renal cancer
by: A. A. Izmailov, et al.
Published: (2023-09-01)

Combining JAK Inhibitors with Immune Checkpoint Inhibitors: Overcoming Resistance in Cancer Treatment
by: Hai‐Jing Zhong
Published: (2025-03-01)

Immune Checkpoint Inhibitors to Treat Malignant Lymphomas
by: Magdalena Witkowska, et al.
Published: (2018-01-01)

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events
by: Maria Luisa De Perna, et al.
Published: (2025-08-01)

Managing Immune Checkpoint Inhibitor Pneumonitis in the ICU
by: Kristina Montemayor, MD, MHS, et al.
Published: (2025-03-01)

Subacute parkinsonism induced by immune checkpoint inhibitors
by: Lénia Silva, et al.
Published: (2024-12-01)

Efficacy of immune checkpoint inhibitors for in-transit melanoma
by: Victoria Atkinson, et al.
Published: (2020-05-01)

Immune Checkpoint Inhibitor Use in Microscopic Colitis
by: Natalie Farha, et al.
Published: (2022-06-01)

Immune Checkpoint Inhibitor-Associated Transverse Myelitis
by: Ömer Faruk Turan, et al.
Published: (2024-12-01)

Immune checkpoint inhibitors in pediatric hematologic malignancies
by: I. V. Gribkova
Published: (2023-05-01)

Immune Checkpoint Inhibitors and Their Impact on Thoughts, Feelings, and Behavior: Cognitive and Psychiatric Manifestations of Immune Checkpoint Therapy
by: Jai Ahuja, et al.
Published: (2025-03-01)

Clinical features of immune checkpoint inhibitor-related pneumonitis in older patients with lung cancer receiving immune checkpoint inhibitors-based therapy: a retrospective study
by: Jiafan Liu, et al.
Published: (2025-04-01)

Immune checkpoint inhibitors in metastatic colorectal cancer therapy (a review)
by: P. P. Sorochan, et al.
Published: (2022-07-01)

Immune Checkpoint Inhibitor Therapy for Prostate Cancer: Present and Future Prospectives
by: Vikrant Rai
Published: (2025-05-01)

Immune checkpoint Inhibitor-Induced Autoimmune hemolytic anemia in endometrial cancer
by: Michael Danziger, et al.
Published: (2025-06-01)

Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer
by: Corti C, et al.
Published: (2025-04-01)

Immunotherapeutic Potential of Lactobacillus Species as Immune Checkpoint Inhibitors in Cancer Immunotherapy
by: Renukadevi J, et al.
Published: (2025-01-01)

Highlights on immune checkpoint inhibitors in non–small cell lung cancer
by: Meng Shen, et al.
Published: (2017-03-01)

Beyond the horizon: Immune checkpoint inhibitors reshaping the landscape of urothelial cancer
by: Ojas Patel
Published: (2024-10-01)

Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy
by: Jiayuan Le, et al.
Published: (2025-12-01)

Nanomaterials and immune checkpoint inhibitors in cancer immunotherapy: the synergistic innovation prospects
by: Jing Chen, et al.
Published: (2025-06-01)

Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors
by: Jonathan L Curry, et al.
Published: (2025-08-01)

Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
by: Min Li, et al.
Published: (2025-03-01)